Repare Therapeutics Inc. (RPTX)
2.650
+0.020 (0.76%)
Inactive · Last trade price
on Jan 27, 2026
Repare Therapeutics Employees
Repare Therapeutics had 129 employees as of December 31, 2024. The number of employees decreased by 50 or -27.93% compared to the previous year.
Employees
129
Change (1Y)
-50
Growth (1Y)
-27.93%
Revenue / Employee
$92,016
Profits / Employee
-$559,690
Market Cap
114.24M
Employees Chart
RPTX News
- 7 weeks ago - Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc. - Business Wire
- 2 months ago - Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration - Business Wire
- 3 months ago - Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - Business Wire
- 3 months ago - Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 4 months ago - Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga
- 4 months ago - Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. - Business Wire
- 5 months ago - Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire
- 7 months ago - Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - Business Wire